11:13 AM EDT, 07/22/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.56% to 1,478.37 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk ( NVO ) and telecommunications company Nokia ( NOK ) , which rose 2.5% and 1.4% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and brewing company Anheuser-Busch InBev ( BUD ) , which were up 1.3% and 1.2% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Cellectis ( CLLS ) , which fell 3.9% and 3.2% respectively. They were followed by biopharmaceutical companies Genfit ( GNFT ) and Grifols ( GRFS ) , which lost 2.8% and 1.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which advanced 7% and 4.1% respectively. They were followed by communications company WPP ( WPP ) and alcoholic beverage company Diageo ( DEO ) , which increased 2.4% and 2.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Amarin ( AMRN ) , which dropped 3.5% and 1.7% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and cruise line operator Carnival (CUK) 1.1% and 0.7%.